SCOPUS 정보 검색 플랫폼

Volumn 3, Issue , 2002, Pages

Gründe für die ausbleibende Hepatitis-C-Behandlung bei Drogenabhängigen in Opiatsubstitution

Author keywords

Guideline; Hepatitis C; Interferon; Opiate Substitution; Ribavirin

Indexed keywords

EID: 85025916773 PISSN: 14399903 EISSN: 1439989X Source Type: Journal
DOI: 10.1055/s-2002-32773 Document Type: Article

Times cited : (3)

References (12)

1
- 0035811625
- Hepatitis C Virus Infection
- Lauer GM, Walker BD. Hepatitis C Virus Infection. New England Journal of Medicine 2001; 345: 41–52
- (2001) New England Journal of Medicine , vol.345 , pp. 41-52
- Lauer, G.M.¹ Walker, B.D.²

2
- 0034718227
- The Natural History of Hepatitis C Virus Infection: Host, Viral and Environmental Factors
- Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. The Natural History of Hepatitis C Virus Infection: Host, Viral and Environmental Factors. JAMA 2000; 284: 450–456
- (2000) JAMA , vol.284 , pp. 450-456
- Thomas, D.L.¹ Astemborski, J.² Rai, R.M.³ Anania, F.A.⁴ Schaeffer, M.⁵ Galai, N.⁶ Nolt, K.⁷ Nelson, K.E.⁸ Strathdee, S.A.⁹ Johnson, L.¹⁰ Laeyendecker, O.¹¹ Boitnott, J.¹² Wilson, L.E.¹³ Vlahov, D.¹⁴

3
- 0033581714
- Hepatitis B und C bei intravenös Drogenkon-sumierenden in der Schweiz
- Steffen T, Gutzwiller F. Hepatitis B und C bei intravenös Drogenkon-sumierenden in der Schweiz. Praxis 1999; 88: 1937–1944
- (1999) Praxis , vol.88 , pp. 1937-1944
- Steffen, T.¹ Gutzwiller, F.²

4
- 0034802218
- Estimating Progression to Cirrhosis in Chronic Hepatitis Virus Infection
- Freeman A. Estimating Progression to Cirrhosis in Chronic Hepatitis Virus Infection. Hepatology 2001; 809–816
- (2001) Hepatology , pp. 809-816
- Freeman, A.¹

5
- 0034619946
- Peginterferon alfa-2a in Patients with Chronic Hepatitis C
- Zeuzem S, Feinman V, Rasenack J, Heathcote J, Lai M, Gane E, OGrady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda M.J. Peginterferon alfa-2a in Patients with Chronic Hepatitis C. New England Journal of Medicine 2000; 343: 1666–1672
- (2000) New England Journal of Medicine , vol.343 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, V.² Rasenack, J.³ Heathcote, J.⁴ Lai, M.⁵ Gane, E.⁶ OGrady, J.⁷ Reichen, J.⁸ Diago, M.⁹ Lin, A.¹⁰ Hoffman, J.¹¹ Brunda, M.J.¹²

6
- 0035934568
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
- Manns M, McHutchinson JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958–965
- (2001) Lancet , vol.358 , pp. 958-965
- Manns, M.¹ McHutchinson, J.G.² Gordon, S.C.³ Rustgi, V.K.⁴ Shiffman, M.⁵ Reindollar, R.⁶ Goodman, Z.D.⁷ Koury, K.⁸ Ling, M.⁹ Albrecht, J.K.¹⁰

7
- 0000427158
- EASL International Consensus Conference on Hepatitis C: Paris, 26–27 February 1999: consensus statement
- Suppl 1
- EASL International Consensus Conference on Hepatitis C: Paris, 26–27 February 1999: consensus statement, J Hepatol 1999; Suppl 1:3–8
- (1999) J Hepatol , pp. 3-8

8
- 0031584956
- Management of hepatitis C
- Bethesda: Md: National Institutes of Health
- Management of hepatitis C. NIH consensus statement. Bethesda: Md: National Institutes of Health 1997; Vol. 15, no. 3
- (1997) NIH consensus statement , vol.15 , Issue.3

9
- 0035913261
- Is It justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?
- Edlin BR, Seal KH, Lorvick J, Krai AH, Ciccarone DH, Moor LD, Lo B. Is It justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users? New England journal of Medicine 2001; 345: 211–214
- (2001) New England journal of Medicine , vol.345 , pp. 211-214
- Edlin, B.R.¹ Seal, K.H.² Lorvick, J.³ Krai, A.H.⁴ Ciccarone, D.H.⁵ Moor, L.D.⁶ Lo, B.⁷

10
- 0035913229
- Treatment of Chronic Hepatitis C in Active Drug Users
- Davis GL, Rodrigue JR. Treatment of Chronic Hepatitis C in Active Drug Users. New England Journal of Medicine 2001; 345: 215–217
- (2001) New England Journal of Medicine , vol.345 , pp. 215-217
- Davis, G.L.¹ Rodrigue, J.R.²

11
- 85025956172
- In: AIDS-Forschung Schweizer Nationalfonds zur Forderung der wissenschaftlichen Forschung (Hrsg) (Zusammenfassung unter www.arud.ch/fachbeitraege/prometheus.htm) Nov.
- Flepp M. Prometheus, Projekt zur Abschatzung von Bedurfnis, Mach-barkeit und Compliance einer antiretroviralen HIV-Therapie bei Dro-genbenutzerlnnen. In: AIDS-Forschung Schweizer Nationalfonds zur Forderung der wissenschaftlichen Forschung (Hrsg). (Zusammenfassung unter www.arud.ch/fachbeitraege/prometheus.htm) Nov. 2000
- (2000) Prometheus, Projekt zur Abschatzung von Bedurfnis, Mach-barkeit und Compliance einer antiretroviralen HIV-Therapie bei Dro-genbenutzerlnnen
- Flepp, M.¹

12
- 85025939223
- Vorläufige Resultate: www.arud.ch/fachbeiträge.htm
- Huber M, Schmid P. Therapy of Chronic Hepatitis C in Patients Participating in Official Opiatsubstitution Programs. Vorläufige Resultate: www.arud.ch/fachbeiträge.htm
- Therapy of Chronic Hepatitis C in Patients Participating in Official Opiatsubstitution Programs
- Huber, M.¹ Schmid, P.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.